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Polymorphous light eruption (PLE) is a common photo­
dermatosis of unknown etiology. It affiicts mainly fair­
skinned patients, with a preponderance of young females. 
There is, however, no absolute restriction as to age, sex, 
or race. 
Clinical variants include the papular, vesiculo-bullous, 
and hemorrhagic variety, as well as plaque, erythema mul­
tiforme-like, and insect bite (strophulus)-like types. Skin 
lesions appear only in certain exposed areas hours or a few 
days after intense sunshine, and are nearly always mono­
morphous in the same patient. The rash subsides sponta­
neously within several days without leaving scars. 
The histopathologic picture is characteristic and shows 
a perivascular lymphocytic inftltrate in the upper and mid­
dle corium with subepidermal edema, vacuolization of basal 
I t was recognized in the early 19th century that certain ecze­matous reactions were caused by sunlight. Willan [1] was the first to use the term "eczema solare." In 1879 Sir Jonathan Hutchinson [2] presented 14 patients under the diagnosis "summer prurigo. " There is reason to believe that "prurigo 
aestivalis," "prurigo adolescentium," and "acne prurigo" syn­
onymously designated similar sun-induced skin disorders. Rasch, 
in 1900 [3], simplified the terminology by introducing the term 
"polymorphous light eruption (PLE). " This designation was widely 
accepted to characterize urticarial, papular, vesicular, and ecze­
matous reactions precipitated by light [4]; however, it did not 
clarify the nosology of photodermatoses. 
A variety of sunlight-evoked eruptions, such as solar urticaria, 
hydroa vacciniforme, porphyrias, photoallergic dermatitis, pho­
tosensitive erythema multiforme, and lupus erythematosus (LE) 
fell under this diagnosis. It was only during the past decades that 
these differential diagnoses have been separated and polymor­
phous light eruption has been defmed as a clinical entity [5-8). 
Until now, however, it remains difficult, if not impossible, to 
distinguish in certain patients between polymorphous light erup­
tion and light-induced subacute or discoid cutaneous lupus ery­
thematosus, or photosensitive erythema multiforme. 
This review describes the growing knowledge about PLE. We 
put forward our concept of the disease as a distinct entity with 
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Abbreviations: 
DLE: discoid lupus erythematosus 
LE: lupus erythematosus 
MED: minimal erythemal dose 
PLE: polymorphous light eruption 
PUV A: photochemotherapy (psoralen + UV A) 
SCLE: subacute cutaneous lupus erythematosus 
UV A: ultraviolet A 
UVB: ultraviolet B 
cells, and spongiosis in the lower epidermis. The most 
important differential diagnoses are solar urticaria, pho­
tosensitive erythema multiforme, and lupus erythemato­
sus. 
The action spectrum of PLE is under debate. Repro­
duction of skin lesions has been reported with UVB, UV A, 
and, rarely, visible light, with UVA probably being the 
most effective part of the spectrum. 
More important than treatment of PLE is prophylaxis. 
UV A- and UVB-effective sunscreens are of some help. 
Phototherapy and especially photochemotherapy (psoralen 
+ UV A; PUV A) offer effective ways to decrease light 
sensitivity. Systemic treatment with chloroquine or f3-car­
otene has been disappointing. ] Invest Dermatol 88:325-385, 
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several morphologic variants. O ur experience is based on obser­
vations in more than 250 patients in the years from 1977 to 1985 
[8-11). 
CLINICAL FEATURES 
Polymorphous light eruption is a very common photodermatosis, 
but the true prevalence among the population is not known. In 
a survey of 271 apparently healthy subjects, 10% gave a history 
consistent with PLE [12]. Many persons are aware of a transient 
"sun allergy" but never visit a dermatologist because they know 
how to manage the problem by themselves. Individual suscep­
tibility varies greatly, and only the most severely afflicted patients 
are seen by physicians. In many patients, PLE appears during the 
first days of vacationing on the beach or in high altitudes. When 
the patient returns home the eruption has resolved spontaneously 
and the pliysician who is asked for help can only conceive a 
diagnosis by the patient's history. 
Polymorphous light eruption seems to occur most frequently 
among fair-skinned populations. Large series are reported from 
Scandinavian countries [13,14], but the eruption is not confmed 
to a certain race or skin color [7]. It has been reported in Blacks, 
Orientals, and in Native North and Latin Americans [15,16]. 
Among the latter, the familial occurrence is a characteristic fea­
ture. This peculiar photodermatosis might represent an entity 
different from PLE observed in whites [17]. Inheritance in an 
autosomal-dominant mode with a reduced penetrance has been 
reported in 56% of patients evaluated in Finland [18] and in 75% 
of Canadian Inuit patients [19]. In other series, genetic predis­
position ranged from 3-45%. Jansen [18] suggested that patients 
in other reports might not have been questioned as thoroughly 
and, therefore, genetic predisposition in general might be under­
estimated. 
There is agreement that the time of onset is most commonly 
during the early adult life [7,13], but the eruption may also start 
in childhood. In children the face and ears frequently are involved. 
Similar cases have been described under the designation ''juvenile 
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spring eruption" [20,21], which is probably part of the PLE spec­
trum. Actinic prurigo [22,23], however, is in our view a separate 
disorder that bears resemblance to the hereditary variant of PLE 
among North, Central, and South American Natives (18,24]. 
Features that distinguish these disorders from PLE are involve­
ment of non-sun-exposed areas, lack of complete clearing during 
the winter season, and presence of chronic eczematous lesions. 
In our experience, 90% of PLE patients are women. This is in 
accordance with the findings of Clorius and Jung [6] and Jansen 
[13]. Others have found a preponderance of men [25,26] or an 
equal sex distribution [27,28]. The reason that, in some studies, 
women are more commonly afflicted is not well understood. It 
is possible diat the preponderance of females does not reflect the 
true prevalence, which might be equal, but rather might reflect 
a higher rate of reporting of the rash by women. 
Lesions of PLE are confined to sun-exposed body sites. In 
contrast to others [5,7,13] we have neither observed lesions on 
areas covered by clothing nor a tendency of the eruption to gen­
eralize. In our experience, PLE is confined to certain sites of 
predilection even when large areas are sun-exposed. In order of 
decreasing frequency of involvement, these sites are: V-neck, 
dorsal forearm and back of hands, upper arms, face, shoulders, 
thighs, and lower legs. Variations among different patients occur. 
In exquisitely sensitive individuals larger parts of the trunk are 
involved, too. Jansen [13] notes that lips and eyes are frequently 
involved, and reports that patients experience general symptoms, 
like chills, headache, fever, and nausea after sun exposure. 
The reaction is of a delayed type. Lesions appear from several 
hours to a few days after intense sun exposure. A characteristic 
sequence of events is reported by most patients, and the dynamics 
of the lesions can be observed when PLE is experimentally evoked 
by phototesting. Itching occurs first; it is followed by patchy 
erythema. Finally, distinct lesions emerge, which may coalesce. 
The sequence from itchy, patchy erythema to sparsely distributed 
and then densely aggregated skin lesions requires increasing amounts 
ofradiation energy. Lesions are present for hours or several days 
and resolve spontaneously without residues when further sun 
exposure is avoided. Scaling, hyperkeratosis, lichenification, or 
scarring are not primary lesions in PLE. These changes may occur 
secondarily due to rubbing or scratching and prolonged sun ex­
posure. Also the clinical picture might be altered by a concomitant 
sunburn reaction. The majority of patients experience seasonal 
recurrences over many years, with decreasing sensitivity after 
repeated sun exposures. Finally, the problem may resolve spon­
taneously after many years [13,29]. 
Many patients experience the elicitation of skin lesions by sun­
light through window glass, e.g., in airplanes, cars, and trains. 
This was already observed by early authors [25] and indicates 
that the action spectrum is not confined to sunburn radiation. 
MORPHOLOGIC VARIANTS 
Most authors agree that there are different morphologic variants, 
with the papular variety being the dominant type [13,28,30]. 
Lamb et al [31] and Epstein [32,33] in their series distinguished 
plaque, prurigo-like, and erythema multiforme-like types from 
the papular, eczematous, and erythematous variety. The latter 
was designated erythema solare perstans. In his review [7] Epstein 
refers to small papules, large papules that may coalesce and form 
plaques, papulovesicular lesions, erythema multiforme-like le­
sions, prurigo-like nodules, and an eczematous response that may 
become secondarily lichenified by rubbing and scratching. Re­
cently, a vesiculobullous variant of PLE was described [34,35]. 
In our view, diffuse erythematous response, eczematous re­
actions, and prurigo-like nodules are not part of the PLE spec­
trum. These lesions characterize separate light-induced disorders, 
which comprise differential diagnoses of PLE. Widespread diffuse 
erythema following sun exposure might occur in systemic LE or 
in the presence of a phototoxic photosensitizer. Eczema in ex­
posed areas is a feature of photoallergy, photosensitive eczema, 
persistent light reaction, light-aggravated atopic eczema, or air-
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borne contact dermatitis. Prurigo associated with sun exposure 
might by seen in actinic prurigo, which represents an entity sep­
arate from PLE. The reason we do not observe eczematous lesions 
in our patients might be the lack of chronic exposure to high­
intensity solar radiation. In the F. R. G. the summer season is 
short and longer periods of sunny weather conditions are rare. 
In our patients [8,11] the papular type, along with the hem­
orrhagic and insect bite (strophulus)-like varieties, the plaque 
type, the vesiculobullous type, and an erythema multiforme-like 
type make up the spectrum of PLE. We do not share the opinion 
that the clinical picture might be polymorphous in the same in­
dividual [5,6] or that combination or transition between the var­
ious types might occur [7]. In our series skin lesions were mon­
omorphous in any one patient. 
Papular Type It is the most common type of PLE. Small 
papules or papulovesicles are disseminated or densely aggregated 
on a patchy erythema (Figs lA, 2A). 
Hemorrhagic Type Rarely, the papular lesions are hemor­
rhagic. 
Insect bite (Strophulus)-like Type This is a peculiar, rare 
variety of the papular type. The lesions are few, scattered, and 
consist of small urticarial papules topped by a tiny vesicle. 
Plaque Type This is the second most common variety in our 
patients. It occurs frequently on the face [7] and resembles sub­
acute cutaneous lupus erythematosus (SCLE), with its sharply 
demarcated, erythematous, elevated, often urticarial plaques. 
Erythema Multiforme-like Type It shows typical target le­
sions and occurs less frequently. 
Vesiculobullous Type It consists of tense vesicles and small 
bullae on an erythematous base. It seems to be frequent among 
North American women vacationing to Hawaii [34]. In Europe 
it is very rarely observed [35]. 
HISTOPATHOLOGY AND 
IMMUNOHISTOPATHOLOGY 
In 1960 Wright and Winer [36] gave a description of the histo­
pathologic pattern seen in PLE that has gained wide acceptance. 
They found parakeratosis, subepidermal edema, vascular dilata­
tion, and lymphocytic infiltration. Sometimes acanthosis, liq­
uefaction degeneration of the basal layer, and diminished elastic 
fibers were observed. McGrae and Perry [5] stressed the similar­
ities to lymphocytic infiltration Jessner. Lamb et al [26], as well 
as Lever and Schaumburg-Lever [37] distinguished the plaque 
type of PLE from LE by absence of vacuolar alteration of basal 
cells, a view that did not hold true [7,8,38]. The main features 
characteristic for PLE are observed in the common papular type 
[7,8]. In other morphologic variants, this basic pattern is also 
prominent, but certain features might be pronounced or addi­
tional features superimposed. 
The pattern of PLE, seen in the papular type, shows a superficial 
and deep perivascular lymphocytic infiltrate with an interstitial 
component in the upper dermis. There are subepidermal edema 
and vacuolization of basal cells, exocytosis of lymphocytes, and 
focal spongiosis. Sunburn cells are notably absent or sparse (Figs 
lB,2B). 
In the plaque type the infiltrate tends to be lichenoid, subepi­
dermal edema is pronounced, and spongiosis is widespread, in­
volving the lower epidermis. 
The erythema multiforme-like type exhibits a prominent su­
bepidermal edema sometimes forming a blister, and few extra­
vasated erythrocytes. Epidermal necrosis may or may not be 
present. 
In the vesiculobullous type spongiotic vesicles and subepider­
mal blisters are formed. 
The insect bite (strophulus)-like type shows focal necrosis in 
the upper malpighian layer, and in the hemorrhagic type there is 
notable extravasation of erythrocytes. 
Figure 2. PLE, papular type, experimentally induced lesions. 
A, Urticarial papules that coalesce emerged in the moderately 
pigmented test area on the upper arm 24 h after irradiation with 
toO J/cm2 UVA (UVASUN 3000); B, Superficial and deep per­
ivascular lymphocytic infiltrate with subepidermal edema, vac­




Figure 1. PLE, papular type, genuine lesions. A, Papules scat­
tered on chest 48 h after sun exposure; B, Histopathology from 
another patient with similar lesions shows perivascular and in­
terstitial lymphocytic infiltrate in the upper corium with subep­
idermal edema, vacuolization of basal cells, and spongiosis. 
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Neutrophils and eosinophils are only present in a few cases [7]. 
We have noted them only in the vesiculobullous type. This is, 
however, inconsistent with other reports [34]. 
Using monoclonal antibodies to defme subsets of infiltrating 
mononuclear cells in papular PLE, Muhlbauer et al [39] found 
that the perivascular infiltrate was predominandy composed of 
T cells with a slight but inconsistent preponderance of cyto­
toxic/suppressor cells over helper/inducer cells. Macrophages 
represented less than 5% of the infiltrating cells. Langer­
hans/indeterminate cells were found to be increased in number. 
The same group [40] studied PLE by direct immunofluores­
cence technique and detected intervascular and focal perivascular 
deposition·of fibrin. In some patients, C3 and IgM was found in 
the walls of venules. The lupus band test was negative in all 
subjects. Recendy, Moncada et al [41] found a predominance of 
T helper cells and Ia + cells in the dermal infiltrate of PLE. 
ACTION SPECTRUM 
The action spectrum ofPLE is not known. There have been many 
debates about the wavelength and energy requirements for elic­
iting skin lesions. Experimental results are conflicting and some­
times contradictory. Factors that may relate to the reported var­
iability include differences in individual susceptibility, seasonal 
variations, differences in test sites, light sources, and interpreta­
tion of test results, as well as the clinical variety ofPLE, including 
geographic differences. Many investigators report the induction 
of skin lesions with sunburn radiation between 280 and 320 om 
[32,33,42,43,44]. Most of these authors used radiation from high­
pressure mercury or xenon lamps or carbon arc sources with 
appropriate filters. In some instances responses to UVC were 
noted [33]. 
On the other hand, Langhof and Sprossig [45], Wiskemann 
and Wulf[46], and Gschnait et al [47] were able to reproduce skin 
lesions ofPLE with long-wave UV light (UVA). In a multitude 
of experimental studies, various authors came to the conclusion 
that the action spectrum might range from UVB, to UV A, and 
into visible light [14,27,44,48-51]. In some instances, an additive 
effect of infrared radiation was observed [13,14]. 
During the years from 1977 to 1985 we tried to induce skin 
lesions experimentally in more than 250 patients. Until 1982, 180 
patients were tested by using various procedures [8]. Monochro­
matic light, both UV A and UVB, as well as polychromatic UV A 
in doses up to 40 J/ cm2 failed to elicit PLE. When UV A from a 
high-intensity apparatus (UV ASUN 3000; Mutzhas, Munich, FRG) 
[52] was given in doses of 60-100 J/cm2, up to 90% of patients 
developed lesions ofPLE if stringent requirements were met (Ta­
ble I). Adhering to the same experimental procedure but using 
polychromatic UVB in minimal erythemal doses (MED) up to 
4, we were unable to reproduce PLE at that time; however, only 
a few patients were tested. 
Recendy, we have extended our experience to another 90 pa­
tients. These were tested with UV A and UVB (UV 800 equipped 
with fluorescent bulbs, Philips TL 12; Waldmann, Villingen­
Schwenningen, FRG) on a contralateral or adjacent skin site, fol­
lowing the method described (Table I). About 60% of patients 
showed lesions ofPLE; out of this group 75% revealed sensitivity 
to UVA, 10% to UVB, and 15% reacted to both UV A and UVB 
[11]. The smaller yield of positive reactions compared with the 
previous study [8] might be due to the fact that some patients 
were tested in summer or fall, at a time when their skin was less 
UV sensitive due to hardening. 
Similar results were found by Ortel et al [53], who were able 
to reproduce skin lesions in 50% of 142 patients. In 56% the 
eliciting wavelengths were found in the UV A range, in 17% in 
the UVB spectrum, and in 26% in both. 
In view of these data it appears that, in the majority of PLE 
patients, long-wave UV is most effective in eliciting skin lesions. 
A small subgroup of patients shows additional sensitivity to UVB 
or may react to UVB exclusively. These findings are in accord­
ance with the observation that eruptions of PLE are frequendy 
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evoked by sun exposure through window glass while patients are 
riding on trains, airplanes, or in cars. Furthermore, sunburn is 
not a prominent feature in PLE, neither clinically nor micro­
scopically. 
The question as to whether erythemal or pigmentary responses 
to solar radiation may differ from normal reactions in patients 
with PLE has stimulated research that produced confticting. ex­
perimental data. Thune [14] as well as others [54] found the MED 
of sunburn radiation lowered in patients with PLE. In contrast, 
Jansen [55] reported normal values, perhaps with a slighdy de­
layed fading of the erythema; pigmentary responses were also 
found to be normal. 
We could not discern any differences in MED-UVB or pig­
mentary reactions induced by UV A between patients with PLE 
and normal controls [9]. Others, too, have questioned the use­
fulness of MED-UVB as a diagnostic parameter [7]. 
DIFFERENTIAL DIAGNOSIS 
The diagnosis of PLE is based on a patient's histo.ry and clinical 
features of lesions. The time course of PLE, with its onset hours 
after intense sun exposure and spontaneous fading (without res­
idue) of lesions within hours or days is very characteristic. It aids 
in establishing the diagnosis when the patient presents without 
skin lesions. A diagnosis can be made almost with certainty when 
the patient presents with a typical rash or when PLE is reproduced 
by phototesting in the laboratory. Biopsies of genuine or exper­
imentally induced lesions may confirm the diagnosis, if other 
differential diagnoses cannot be excluded clinically. Staining with 
hematoxylin and eosin suffices; special stains are of little help, 
perhaps with the exception of direct immunofluorescence tech­
nique, if lupus erythematosus is suspected. 
It is our belief that chronic skin lesions with pronounced epi­
dermal changes are not part of the PLE spectrum. Thus, light­
induced disorders showing eczematous lesions, e. g., photoallergic 
dermatitis, photosensitive eczema, and persistent light reaction 
are excluded from PLE by their morphology. 
Solar urticaria may mimic the plaque type ofPLE. Time course 
of whealing and the reproduction of typical hives using low doses 
of electromagnetic radiation are characteristic for solar urticaria. 
Photosensitive erythema multiforme is a rare condition [56]. It 
is difficult to separate this disorder from the erythema multiforme 
type ofPLE. Clinical and histologic pictures are very similar [57]. 
The following features may help to differentiate light-sensitive 
erythema multiforme from PLE: (1) The former occurs 1-14 days 
after sun exposure. (2) Immune complexes may be detected in 
the initial stage, and the lymphohistiocytic infiltrate is perivascular 
and interstitial in the upper corium. (3) Sometimes eosinophils 
and extravasated erythrocytes are prominent, and the epidermis 
shows focal necrosis. 
The deposition of immune complexes in venules of the skin 
triggered by UV erythema has been discussed as the underlying 
pathogenetic mechanism in photosensitive erythema multiforme 
[58]. 
Lupus erythematosus is the most important differential diag­
nosis, clinically and histologically. Subacute cutaneous lupus er­
ythematosus and the tumid type of discoid LE (DLE) may present 
with lesions very similar to the plaque type ofPLE. In LE, how­
ever, waxing and waning of lesions are not as closely correlated 
to sun exposure as in PLE. Lesions usually persist for several 
weeks or months even without further UV exposure. When LE 
lesions are induced by experimental UV irradiation [59] it takes 
at least several days, in most cases 1-2 weeks or longer, for lesions 
to appear. This prolonged time course differs from PLE. 
Histologically, the lymphocytic infiltrate in LE frequendy ex­
tends perivascularly and around the adnexa in the deeper corium. 
There might be mucin deposition between collagen bundles [60]. 
Subepidermal edema is not pronounced, and liquefaction degen­
eration, if present, is confined to the epidermal basal cell layer. 
Spongiosis is absent. Sometimes neutrophils are seen in vessels 
of the superficial plexus. In most cases of PLE the perivascular 
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Size of test area 
Light source 
UV dose 
Before the PLE season starts 
Previously involved body areas. Avoid 
pigmented skin 
No less than 5 x 10 cm 
Use polychromatic UV in large doses 
UV A: 60-100 J/ cm2 
UVB: 2 MED 
Repeat irradiations on day 2 and 3, if necessary 
lymphocytic infiltrate reaches only into the mid-dermis. Subep­
idermal edema is a prominent feature. Vacuolization accompanied 
by spongiosis occurs in the 2 or 3 suprabasal cell layers. Intra­
cellular and intercellular edema of the lower part of the epidermis, 
in combination with subepidermal edema, gives the dermoepi­
dermal interface a spongy appearance. The histopathologic dif­
ferences mentioned are prominent only in fully developed lesions. 
In the initial stage of LE or PLE it is extremely difficult, sometimes 
impossible, to distinguish between the two diseases on histo­
pathologic grounds. Direct and indirect immunofluorescence are 
of limited value because they may yield negative results in early 
stages of LE or may be found positive in some patients with PLE 
who, however, do not meet other criteria of LE [29]. It is our 
impression that there might be a subgroup of patients that cannot 
be separated clearly either from DLE, SCLE, or PLE. It is con­
ceivable that these patients eventually progress into LE. This view 
is, however, not substantiated by follow-up studies [29,30], in 
which PLE patients were not found to develop LE. 
THERAPY AND PROPHYLAXIS 
Some patients may experience a cooling and beneficial subjective 
effect by local application of zinc lotion in acute-stage PLE. Top­
ical or systemic steroids may ameliorate inflammation or itching 
and shorten the eruption. In few patients eruptions of PLE can 
be suppressed by prophylactic systemic steroid treatment. Con­
trolled trials are lacking and it seems inappropriate to treat this 
chronic, intermittent, self-limited, and benign disease with sys­
temic steroids. More important than therapy of the acute eruption 
seems the prevention of further attacks by prophylactic measures. 
Light protection, phototherapy, photochemotherapy and, to some 
extent, systemic drugs offer ways to decrease UV sensitivity. 
Sun protection by protective clothing or staying in the shade 
may prevent PLE. The usefulness of topical sunscreens is limited, 
although sun blockers have been found effective in UVB-sensitive 
patients [62], and broad-band screens (UVB plus UVA) or phys­
ical sunscreens may be beneficial in other patients [8,51,63,64]. 
Systemic treatment with J3-carotene yielded different results. 
Some authors found only modest improvement of UV tolerance 
not sufficient to enable the patient to perform normal outdoor 
activities [65,66], while others report complete remission [14,67] 
(uncontrolled studies). J3-Carotene was also used in combination 
with canthaxanthin [68], a combination recently banned by the 
German Federal Department of Health. In controlled trials [69,70] 
J3-carotene was ineffective in many cases. The same holds true 
for chloroquine [68], although antimalarials, mainly chloroquine 
and quinacrine, have been commonly used to treat PLE [61,71,72]. 
Results have been unimpressive. 
Some authors [73,74] assume that the underlying mechanism 
in PLE is a disturbance in the tryptophan metabolism, with ac­
cumulation of kynurenic acid, which may act as a photosensitizer. 
They advocate treatment with high doses of nicotinamide to re­
duce the level of kynurenic acid and report good therapeutic 
results [74]. There is no proof of this hypothesis. 
In actinic prurigo [75] and PLE [76], thalidomide was helpful, 
but is obsolete in view of the teratogenic effect and neurotoxic 
side effects. Ketoprofen, a nonsteroidal anti-inflammatory agent, 
was shown to be ineffective [69]. 
Phototherapy and photo chemotherapy provide a good protec-
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tive effect. Patients with PLE frequently show "hardening" with 
decreasing UV sensitivity during spring or early summer. It seems 
worthwhile to induce this protective mechanism by controlled 
exposures to sunlight [77] or artificial UV sources [78-80]. Also, 
PUV A treatment was used to prevent further attacks of PLE 
[47,81-84], and was found to be superior to phototherapy 
[53,62,83,85]. Until more is known about the long-term hazards 
of PUVA therapy, patients should be monitored carefully, al­
though the number of exposures and the cumulative UV A doses 
are quite small. We do not advocate PUVA therapy in PLE as 
the treatment of first choice, but inform our patients about the 
benign nature of PLE and recommend sun-protective measures 
in combination with skin "hardening" using natural sunlight. If 
this fails, phototherapy is used. Only those patients who are 
exquisitely sensitive to UV are treated with PUV A therapy in 
our department. The mechanism by which phototherapy or pho­
to chemotherapy induce protection is not completely understood. 
Besides increased melanization and thickening of epidermis and 
stratum corneum, factors that enhance UV absorption in the ep­
idermis and provide a protecting shield for the underlying dermis, 
immunologic mechanisms cannot be excluded. 
HYPOTHESES ON ETIOLOGY AND PATHOGENESIS 
OF PLE 
Apart from the fact that PLE is induced by electromagnetic ra­
diation emanating from the sun, nothing is known about its etiol­
ogy, despite many investigative studies. 
In their search for an endogenous photosensitizer, European 
authors focused on gastrointestinal abnormalities in PLE patients 
[45,86]. Also urinary excretion of an indole derivative, called 
"Kimmig's light band" [87] was described but was not found to 
be specific for PLE [88]. O thers [73,74] put forward the hypoth­
esis that disturbances in the tryptophan metabolism might be the 
cause of photosensitization. None of these theories account for 
the pathomechanism of PLE. 
Many investigators hold the view that PLE is related to a cell­
mediated immunologic reaction [7]. The time course of the re­
action, with a delay after the initiating sun exposure, the clinical 
picture, and histopathologic findings bear similarities to the ecze­
matous reaction of delayed-type hypersensitivity. A relevant pho­
to allergen has not been identified. Functional disturbances of lym­
phocytes have been found only inconsistently. Horkay and Meszaros 
[89] described UV-induced lymphocyte transformation in PLE. 
Also, a defect in the excision repair mechanism in lymphocytes 
of PLE patients was reported [90], but was not confirmed by 
others [91,92]. 
In recent studies on cell-mediated immunity in PLE, a transient 
decrease [93] as well as an increase [41] in number of lymphocytes 
was found; no inhibition of leukocyte migration was detected 
[94]. The number of peripheral T cells and response of peripheral 
lymphocytes to phytohemagglutinin, concanavalin A, and pu­
rified protein derivative of tuberculin was found normal before 
and after PUV A treatment [95]. This argues against the distur­
bance in lymphocyte function as a cause of PLE. 
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